Cargando…
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice
One of the most severe side effects of anti-tumour chemotherapy is mucositis due to drug toxicity for rapidly dividing cells. We show here that anti-DXR monoclonal antibodies can prevent DXR-induced damage. Indeed, apoptosis, confined to the proliferative compartment of the basal mucosa, observed in...
Autores principales: | Balsari, A, Rumio, C, Morelli, D, Sfondrini, L, Nardini, E, Barajon, I, Ménard, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364005/ https://www.ncbi.nlm.nih.gov/pubmed/11747341 http://dx.doi.org/10.1054/bjoc.2001.2188 |
Ejemplares similares
-
Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
por: Morelli, D., et al.
Publicado: (1997) -
Exploiting poly(I:C) to induce cancer cell apoptosis
por: Bianchi, Francesca, et al.
Publicado: (2017) -
Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma
por: Anderson, Colin C., et al.
Publicado: (2020) -
Caspase-3 activation during apoptosis caused by glutathione–doxorubicin conjugate
por: Asakura, T, et al.
Publicado: (1999) -
Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases
por: Le Noci, Valentino, et al.
Publicado: (2019)